FDA approves Lannett's new antidepressant

The Food and Drug Administration approved Lannett's paroxetine extended release tablets.

Paroxetine tablets are intended to treat patients with depression, obsessive-compulsive disorder, anxiety disorders and post-traumatic stress disorder.

The tablets are a generic version of Paxil CR tablets created by Weston, Fla.-based Apotex Technologies.

The company has already begun shipping the medicine to customers.

More articles on supply chain:

Roche's new HPV test earns FDA approval
6 latest FDA approvals
UPMC, IBM team up for better hospital supply chains

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars